Exclusive

Publication

Byline

Location

US Patent Issued to Molly Sandra Shoichet on April 21 for "Hydrogel compositions and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,461, issued on April 21, was assigned to Molly Sandra Shoichet (York, Canada). "Hydrogel compositions and uses thereof" was invented by Mo... Read More


US Patent Issued to University-Industry Cooperation Group of Kyung Hee University on April 21 for "Porous silicon nanoparticle-based drug delivery system inducing reactive oxygen species and self-activation thereof, and method for preparing same" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,462, issued on April 21, was assigned to University-Industry Cooperation Group of Kyung Hee University (Yongin-si, South Korea). "Porous s... Read More


US Patent Issued to The Johns Hopkins University on April 21 for "Tolerogenic artificial antigen-presenting cells" (Maryland Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,463, issued on April 21, was assigned to The Johns Hopkins University (Baltimore). "Tolerogenic artificial antigen-presenting cells" was i... Read More


US Patent Issued to The University of North Carolina at Chapel Hill on April 21 for "AAV-NAGLU vectors for treatment of mucopolysaccharidosis IIIB" (North Carolina Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,465, issued on April 21, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "AAV-NAGLU vectors for treat... Read More


US Patent Issued to University of Florida Research Foundation on April 21 for "Enhanced human opsin promoter for rod specific expression" (Florida Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,466, issued on April 21, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Enhanced human opsin promote... Read More


US Patent Issued to SHANGHAI VITALGEN BIOPHARMA on April 21 for "Recombinant AAV vectors for treating neurodegenerative disorders" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,467, issued on April 21, was assigned to SHANGHAI VITALGEN BIOPHARMA Co. LTD. (Shanghai). "Recombinant AAV vectors for treating neurodegen... Read More


US Patent Issued to Oregon Health & Science University on April 21 for "Oxazine-based fluorophore compounds for nerve-specific imaging" (Oregon Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,468, issued on April 21, was assigned to Oregon Health & Science University (Portland, Ore.). "Oxazine-based fluorophore compounds for ner... Read More


US Patent Issued to The University of North Carolina at Charlotte, OncoTAb on April 21 for "Tumor specific antibody conjugates and uses therefor" (North Carolina, California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,469, issued on April 21, was assigned to The University of North Carolina at Charlotte (Charlotte, N.C.) and OncoTAb Inc. (Marvin, N.C.). ... Read More


US Patent Issued to Arizona Board of Regents on Behalf of the University of Arizona on April 21 for "Nanodroplet with layer-by-layer assembly" (Arizona Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,470, issued on April 21, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.). "Nanodroplet wit... Read More


US Patent Issued to The General Hospital on April 21 for "Cromolyn derivatives and related methods of imaging and treatment" (Massachusetts Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,471, issued on April 21, was assigned to The General Hospital Corp. (Boston). "Cromolyn derivatives and related methods of imaging and tre... Read More